PRIDE

Public Offerings Revolutionized through an Integrated & Digitized Experience

Selmore Pharmaceuticals Limited

Date of Filing of Listing Application at PSX

September 14, 2026

Status of Listing Application

Under Review

Dates of Placement of Prospectus for Public Comments

September 28, 2026 to October 05, 2026

Notice for Public Comments

Download

Public Comments on Prospectus and CTI Responses

Pending

Date of PSX Approval

Pending

Date of SECP Approval

Pending

Dates of Book Building

Pending

Dates of Public Subscription

Pending

Final Prospectus with Dates Approved by PSX

Pending

Subscription Results

Pending

Date of Listing

Pending

Notice of Listing

Pending